Quick Answer
AYTU BIOPHARMA, INC reported Cash And Cash Equivalents At Carrying Value of $30.95 million for the year ending 2025.
- AYTU BIOPHARMA, INC showed an increase of +54.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from AYTU BIOPHARMA, INC's annual report (Form 10-K), filed with the SEC on September 23, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $4.12 million | Q2 2014: $2.64 million | Q3 2014: $1.05 million | Q4 2014: $160.9 thousand | Q1 2015: $1.49 million | Q2 2015: $7.35 million | Q3 2015: $10.07 million | Q4 2015: $10.96 million | Q1 2016: $8.67 million | Q3 2016: $2.75 million | Q4 2016: $5.23 million | Q1 2017: $3.47 million | Q3 2017: $7.02 million | Q4 2017: $3.91 million | Q1 2018: $12.01 million | Q3 2018: $3.96 million | Q4 2018: $17.80 million | Q1 2019: $14.65 million | Q3 2019: $7.01 million | Q4 2019: $5.26 million | Q1 2020: $62.26 million | Q3 2020: $37.91 million | Q4 2020: $62.03 million | Q1 2021: $46.54 million | Q3 2021: $40.31 million | Q4 2021: $35.28 million | Q1 2022: $27.61 million | Q3 2022: $23.81 million | Q4 2022: $19.50 million | Q1 2023: $19.18 million | Q3 2023: $19.96 million | Q4 2023: $19.53 million | Q1 2024: $19.76 million | Q3 2024: $20.11 million | Q4 2024: $20.40 million | Q1 2025: $18.17 million | Q2 2025: $30.95 million | Q3 2025: $32.63 million | Q4 2025: $30.03 million.
- Over the full 13 years of available data (2013 to 2025), AYTU BIOPHARMA, INC's Cash And Cash Equivalents At Carrying Value has grown by 962.3%.
- Historical annual values: Fiscal year 2025: $30.95 million | Fiscal year 2024: $20.01 million | Fiscal year 2023: $22.99 million | Fiscal year 2022: $19.36 million | Fiscal year 2021: $49.65 million | Fiscal year 2020: $48.08 million | Fiscal year 2019: $11.04 million | Fiscal year 2018: $7.01 million | Fiscal year 2017: $802.3 thousand | Fiscal year 2016: $8.05 million | Fiscal year 2015: $7.35 million | Fiscal year 2014: $2.64 million | Fiscal year 2013: $2.91 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: